FDA to Investigate Quality and Effectiveness of Long-Acting Generic Drug Products
FDA to Explore Quality and Viability of Long-Acting Generic Drug Products. Last week, the U.S. Food and Drug Administration (FDA) announced that it is ready to spend nearly one million dollars to study the quality and effectiveness of long-acting generic drug products. According to Regulatory Affairs Professionals Society (RAPS), … [Read more...] about FDA to Investigate Quality and Effectiveness of Long-Acting Generic Drug Products
FDA Allows Sales of 700 Generic Medicines Banned by European Medicines Agency
The European Medicines Agency (EMA) instituted a ban on about 700 generic medicines that were approved based in part on what were said to be flawed clinical studies conducted at GVK BioSciences, a contract research organization based in Hyderabad, India. The U.S. Food and Drug Administration (FDA) said it found no systemic issues … [Read more...] about FDA Allows Sales of 700 Generic Medicines Banned by European Medicines Agency
FDA Says Some Generic ADHD Medications May Not be as Effective
The U,S, Food and Drug Administration (FDA) has raised questions about the effectiveness of two generic medications used to treat attention deficit hyperactivity disorder (ADHD). The agency said in November that generic versions of Concerta, the long-acting version of Ritalin, may not be “therapeutically equivalent” to the brand name … [Read more...] about FDA Says Some Generic ADHD Medications May Not be as Effective
FDA Questions Effectiveness Of Generic ADHD Drugs
Generic ADHD Drugs Effectiveness. Generic medications are supposed to work just as well as their brand name counterparts, but the U.S. Food and Drug Administration (FDA) has raised skepticism about whether or not this is true for some products. In particular, the agency announced last November that two generic medications used to … [Read more...] about FDA Questions Effectiveness Of Generic ADHD Drugs
Supreme Court Debates Liability Limit
Low-Priced Drugs Linked To Injuries The pharmaceutical industry’s collective eyes are focused on a Supreme Court case regarding generic drugs that could very well determine the degree to which the public can hold generic drug makers liable for injuries allegedly caused by these lower-priced copies of branded medication. The … [Read more...] about Supreme Court Debates Liability Limit
FDA urges patients to stop taking generic Lipitor after recall
Specks Of Glass Found In Generic Pills Lipitor. The Food and Drug Administration is warning patients to stop taking the generic form of Lipitor, atorvastatin, after specks of glass were found in pills. According to a CNN.com report, the makers of the generic form of Lipitor, one of the most popular cholesterol drugs, have issued a … [Read more...] about FDA urges patients to stop taking generic Lipitor after recall
National Defective Drug Attorneys Warn That Newly Approved Generic Actos Has Similar Risk Of Bladder Cancer, Other Side Effects
Generic Actos Has Similar Risk Of Bladder Cancer. Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, is warning consumers that generic versions of Actos, like the brand name, carry an increased risk of bladder cancer and other complications. The U.S. Food and Drug … [Read more...] about National Defective Drug Attorneys Warn That Newly Approved Generic Actos Has Similar Risk Of Bladder Cancer, Other Side Effects
KV Pleads Guilty, Agrees to Close ETHEX Generic Drug Plant
KV Will Be Closing Down Its ETHEX Generic Drug Unit. We have long been writing about a series of problems with K-V Pharmaceutical Company. In December, K-V Pharmaceutical said that the U.S. Food and Drug Administration (FDA) accepted its work plan to address the issues. Now, KV Pharmaceutical said it will be closing down its ETHEX … [Read more...] about KV Pleads Guilty, Agrees to Close ETHEX Generic Drug Plant
Generic Digoxin Tablets Recalled
Digoxin Tablets Recalled. Potentially defective digoxin tablets have been recalled by generic drug maker Caraco Pharmaceutical Laboratories, Ltd. According to the recall notice, the tablets may differ in size and therefore could contain too much or too little of the drug's active ingredient. The recall applies to all tablets of … [Read more...] about Generic Digoxin Tablets Recalled
Generic Drugs Raise Questions About Safety
Generic Drugs Raise Questions About Safety. Generic medications have been a godsend to global consumers, allowing millions to buy lifesaving drugs at significantly reduced costs. About 65% of all prescriptions filled in the U.S. are for generics according to the Generic Pharmaceutical Association. But consumers and physicians are … [Read more...] about Generic Drugs Raise Questions About Safety
Drug Maker Withdraws Generic Nefazodone
Nefazodone May Cause Liver Damage. Health Canada announced Monday that generic versions of the antidepressant Serzone are also being pulled from the market. The department will oversee the withdrawal of all generic drugs containing nefazodone, the generic name for the drug marketed as Serzone. The drugs are being withdrawn because … [Read more...] about Drug Maker Withdraws Generic Nefazodone
